Non-invasive serum fibrosis markers: A study in chronic hepatitis

Non-invasive serum fibrosis markers: A study in chronic hepatitis

Introduction: Chronic hepatitis is specified as inflammatory disease of the liver lasting for more than six months. Role of noninvasive fibrosis markers as prognostication factors of the presence or absence of significant fibrosis on liver biopsy of patients with chronic hepatitis is the aim of this...

Full description

Bibliographic Details
Main Authors:	Mohammadreza Abdollahi, Aliasghar Pouri, Morteza Ghojazadeh, Rasoul Estakhri, Mohammadhossein Somi
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences 2015-02-01
Series:	BioImpacts
Subjects:	Chronic Hepatitis Fibrosis Grade Noninvasive Markers Stage
Online Access:	http://journals.tbzmed.ac.ir/BI/PDF/BI-5-17.pdf

Similar Items

Serum Autofluorescence, a Potential Serum Marker for the Diagnosis of Liver Fibrosis in Rats
by: Xin Song, et al.
Published: (2012-09-01)

The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease
by: M A Livzan, et al.
Published: (2016-12-01)

The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients
by: Banu Demet Coskun, et al.
Published: (2015-12-01)

Correlation of biological serum markers with the degree of hepatic fibrosis and necroinflammatory activity in hepatitis C and schistosomiasis patients
by: Clarice Neuenschwander Lins de Morais, et al.
Published: (2010-07-01)

Diagnostic possibilities of methods for the evaluation of liver fibrosis in chronic viral hepatitis
by: A N Navrotsky
Published: (2016-11-01)

Serum N-glycomic markers in combination with panels improves the diagnosis of chronic hepatitis B
by: Ying Qu, et al.
Published: (2012-03-01)

A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION
by: A. A. Ostanin, et al.
Published: (2014-07-01)

Validation of a two‐step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis
by: Hideki Fujii, et al.
Published: (2021-07-01)

Diagnostic Value of Serum Markers of Liver Fibrosis in Patients with HCV-Infection
by: S.L. Melanich
Published: (2013-11-01)

Diagnostic value of serum markers of fibrosis in chronic liver diseases
by: E V Vinnitskaia, et al.
Published: (2013-02-01)

Feasibility and reliability of the FibroScan S2 (pediatric) probe compared with the M probe for liver stiffness measurement in small adults with chronic liver disease
by: Faruq Pradhan, et al.
Published: (2013-01-01)

Diagnostic value of fibronectin discriminant score for predicting liver fibrosis stages in chronic hepatitis C virus patients
by: Abdelfattah M. Attallah, Ph.D., et al.
Published: (2013-01-01)

Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients
by: Pimsiri Sripongpun, et al.
Published: (2020-02-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

Utility and limitations of APRI and FIB4 to predict staging in a cohort of nonselected outpatients with hepatitis C
by: Ana Cláudia de Oliveira, et al.
Published: (2016-05-01)

Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C
by: Dagmara Przekop, et al.
Published: (2021-08-01)

Noninvasive Assessment of Fibrosis Following Ischemia/Reperfusion Injury in Rodents Utilizing Na Magnetic Resonance Imaging
by: Per Mose Nielsen, et al.
Published: (2020-08-01)

RELATIONSHIP OF THE MARKERS OF ENDOTHELIAL DYSFUNCTION AND FIBROSIS IN CHRONIC HEPATITIS AND CIRRHOSIS
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

RELATIONSHIP OF THE MARKERS OF ENDOTHELIAL DYSFUNCTION AND FIBROSIS IN CHRONIC HEPATITIS AND CIRRHOSIS
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

Non-Invasive Indirect Biochemical Markers for Liver Fibrosis
by: Huseyin Kayadibi, et al.
Published: (2014-06-01)

Serum hyaluronic acid as a noninvasive marker of hepatic fibrosis in chronic hepatitis B
by: Geramizadeh Bita, et al.
Published: (2008-01-01)

IMMUNE PREDICTORS OF FIBROGENESIS AND THEIR APPLICATION FOR NON-INVASIVE DIAGNOSTICS OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
by: M. V. Shipunov, et al.
Published: (2012-05-01)

Non-invasive serum markers and transient elastography in staging advanced chronic hepatitis C
by: Arida Buivydienė, et al.
Published: (2016-01-01)

Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?
by: José M. Ladero, et al.
Published: (2012-09-01)

Serum hyaluronan and collagen IV as non-invasive markers of liver fibrosis in patients from an endemic area for schistosomiasis mansoni: a field-based study in Brazil
by: Carolina Coimbra Marinho, et al.
Published: (2010-07-01)

Prevalence of hepatitis C and fibrosis stage per age group in Lebanese population
by: Antoine Abou Rached, et al.
Published: (2017-11-01)

Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: A preliminary approach
by: Mohamed Alboraie, et al.
Published: (2014-01-01)

Advances of Hepatic Fibrosis-Associated Serological Markers in the View of Translational Medicine
by: Lin LIU, et al.
Published: (2016-03-01)

MARKERS OF BONE METABOLISM IN PATIENTS WITH CYSTIC FIBROSIS.
by: Bojana Naydenova- Stoeva
Published: (2015-11-01)

Non-invasive methods for the assessment of hepatic fibrosis: transient elastography, hyaluronic acid, 13C-aminopyrine breath test and cytokeratin 18 fragment
by: Gian Paolo Caviglia, et al.
Published: (2014-01-01)

The diagnostic value of non-invasive serum liver fibrosis indices in the prediction of portal hypertension in cirrhotic patients: a cross-sectional study
by: Masood Faghih Dinevari, et al.
Published: (2020-02-01)

Serum hyaluronic acid as a noninvasive marker of hepatic fibrosis in chronic hepatitis c patients
by: Soheir M Abd-Elghany, et al.
Published: (2016-01-01)

Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
by: Mendes LC, et al.
Published: (2018-04-01)

Measurement of serum laminin level during the treatment of chronic hepatitis
by: Parsian H (PhD), et al.
Published: (2010-03-01)

Assessment of non-invasive models for liver fibrosis in chronic hepatitis B virus related liver disease patients in resource limited settings
by: Rakesh Shrivastava, et al.
Published: (2013-01-01)

Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis
by: Kei Moriya, et al.
Published: (2021-06-01)

Oral submucous fibrosis: A clinico-histopathological study in Chennai
by: Kiran Kumar K, et al.
Published: (2007-01-01)

AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis
by: Aurora Loaeza-del-Castillo, et al.
Published: (2008-10-01)

FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients
by: Xiao-Jie Lu, et al.
Published: (2020-09-01)

Predictors of histological activity and fibrosis in chronic Hepatitis C infection: A study from North India
by: Singh Sompal, et al.
Published: (2010-04-01)